Your browser doesn't support javascript.
loading
Transforming the Perioperative Treatment Paradigm in Non-Metastatic RCC-A Possible Path Forward.
Harshman, L C; Drake, C G; Haas, N B; Manola, J; Puligandla, M; Signoretti, S; Cella, D; Gupta, R T; Bhatt, R; Van Allen, E; Lara, P; Choueiri, T K; Kapoor, A; Heng, D Y C; Shuch, B; Jewett, M; George, D; Michaelson, D; Carducci, M A; McDermott, D; Allaf, M.
Afiliación
  • Harshman LC; Lank Center for Genitourinary Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA, USA.
  • Drake CG; Division of Hematology/Oncology, Herbert Irving Comprehensive Cancer Center, Columbia University Medical Center, New York, NY, USA.
  • Haas NB; Division of Hematology/Oncology, Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA, USA.
  • Manola J; Department of Biostatistics and Computational Biology, Dana-Farber Cancer Institute, Boston, MA, USA.
  • Puligandla M; Department of Biostatistics and Computational Biology, Dana-Farber Cancer Institute, Boston, MA, USA.
  • Signoretti S; Department of Pathology, Brigham and Women's Hospital, Boston, MA, USA.
  • Cella D; Northwestern University Feinberg School of Medicine, Chicago, IL, USA.
  • Gupta RT; Departments of Radiology and Surgery and The Duke Cancer Institute, Duke University Medical Center, Durham, NC, USA.
  • Bhatt R; Division of Hematology-Oncology and Cancer Biology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, USA.
  • Van Allen E; Lank Center for Genitourinary Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA, USA.
  • Lara P; University of California Davis School of Medicine, Sacramento, CA, USA.
  • Choueiri TK; Lank Center for Genitourinary Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA, USA.
  • Kapoor A; Division of Urology, McMaster University, Hamilton, ON, Canada.
  • Heng DYC; Tom Baker Cancer Center, Calgary, AB, Canada.
  • Shuch B; Division of Urology, Yale Cancer Institute, New Haven, CT, USA.
  • Jewett M; Departments of Surgery(Urology) and Surgical Oncology, Princess Margaret Cancer Centre, University Health Network and the University of Toronto, Toronto, ON, Canada.
  • George D; Duke University Departments of Medicine, Surgery, and Pharmacology and Cancer Biology, Division of Medical Oncology, The Duke Cancer Institute, Durham, NC, USA.
  • Michaelson D; Genitourinary Cancer Center, Massachusetts General Hospital, Boston, MA, USA.
  • Carducci MA; Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, MD, USA.
  • McDermott D; Division of Hematology-Oncology and Cancer Biology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, USA.
  • Allaf M; Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, MD, USA.
Kidney Cancer ; 1(1): 31-40, 2017 Jul 26.
Article en En | MEDLINE | ID: mdl-30334002
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Clinical_trials / Prognostic_studies Aspecto: Patient_preference Idioma: En Revista: Kidney Cancer Año: 2017 Tipo del documento: Article País de afiliación: Estados Unidos Pais de publicación: Estados Unidos
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Clinical_trials / Prognostic_studies Aspecto: Patient_preference Idioma: En Revista: Kidney Cancer Año: 2017 Tipo del documento: Article País de afiliación: Estados Unidos Pais de publicación: Estados Unidos